Diagnostic and Biotech

2015 UK Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies-Molecular Diagnostics, Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics

  • VPG172124
  • 415 Pages
  • January 2015
  • Diagnostic and Biotech

2015 UK Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - Molecular Diagnostics, Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics



2015 UK Automated Microbiology Market; is a new analysis of major business opportunities emerging in the U.K. automated microbiology market during the next five years.



The report examines key trends, reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.



Rationale



The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests. 



The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.



The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.



This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding U.K. microbiology market, in evaluating emerging opportunities and developing effective business strategies. 



Market Segmentation Analysis



- Sales and market shares for major suppliers by individual test.



- Volume and sales forecasts for over 100 infectious disease assays by individual test:



- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).



- Review of the market dynamics, trends, structure, size, growth and major suppliers.



Specimen Types



- Urine - Sterile Fluids: Blood, Serum, CSF - Throat Swabs, Respiratory Secretions - Genital Secretions - Stool - Abscess/Wound - Sputum - Saliva



Applications



- Microbial Identification - Antibiotic Susceptibility - Urine Screening - Blood Cultures



Review of Major Automated Systems



- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.



- The report profiles analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.



Infectious Diseases Analyzed in the Report



AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.



Technology Review



- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.



- Global listings of companies developing or marketing microbiology products by individual test.



Competitive Assessments



- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D.



- The companies analyzed in the report include Abbott, Affymetrix, Agilent Technologies, Arca/Nuvelo, Beckman Coulter/Danaher, Becton Dickinson, Biokit, bioMerieux, Bio-Rad, Biotest, Caliper, Cepheid, Decode, Diadexus, Diamedix, DiaSorin, Eiken Chemical, Enzo Biochem, Exact Sciences, Fujirebio/Innogenetics, Hologic/Gen-Probe, Illumina, ID Biomedical/GSK, Kreatech, Li-Cor Biosciences, Life Technology, Lonza, Monogram Biosciences, Myriad Genetics, Nanogen/Elitech, Novartis Diagnostics/Grifols, Orchid CellMark, Ortho-Clinical Diagnostics, Proteome Sciences, Qiagen, Roche, Scienion, Sequenom, SeraCare, Siemens, Sierra Molecular, Shimadzu, Takara Bio, Tecan, Thermo Fisher, Wallac/PE, Wako.



Opportunities and Strategic Recommendations



- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.



- Design criteria for decentralized testing products.



- Alternative market penetration strategies.



- Potential market entry barriers and risks.



Contains 415 pages and 72 tables 



Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Exocrine Pancreatic Insufficiency Market (Mode of Disease management, Type of diagnostic tests and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global C-Reactive Protein Testing Market (Application, Types of Assays and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

C-Reactive Protein Tests are blood tests that measure the levels of C-Reactive Protein. C-reactive protein is a protein that is produced by the liver and its level increase when there ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Medical Image Processing Market (Application, Image Type, Technology and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2014 - 2021

Medical imaging is a technique used for the creating the visual representation of the internal body parts for the purpose of clinical analysis and medical intervention. The use of this technique revels internal structure that is hidden by the skin and bones for the diagnosis and treatment of disease.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Live Cell Imaging Market - Opportunities and Forecast, 2014 - 2020

Live cell imaging is the study of cells in real time using the images obtained from screening systems and microscopes. The technology has altered the approach of scientists to study ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Veterinary Diagnostics Market (Products, Animals, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

North America Clinical Chemistry Analyzer Market - Opportunities and Forecast, 2015 - 2020

A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective ...

July 2017  |   Price:$ 3390    | Pre Book Price:$ 3390

Read More >>

2017 © Copyright Big Market Research

View Pricing >>